1999
DOI: 10.1097/00003246-199906000-00028
|View full text |Cite
|
Sign up to set email alerts
|

N-Acetylcysteine treatment to prevent the progression of multisystem organ failure

Abstract: We found a nonsignificant difference in outcome between NAC and placebo-treated patients. Our results suggest that the initiation of NAC treatment >24 hrs after hospital admission may potentially be harmful, and further studies should be undertaken to investigate the clinical use of the early application of NAC in critically ill patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
64
0
2

Year Published

2001
2001
2013
2013

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 101 publications
(69 citation statements)
references
References 29 publications
3
64
0
2
Order By: Relevance
“…Clinical trials with antioxidants for acute illnesses, such as ALI or sepsis, have been disappointing, and no agent has been shown to be effective in critically ill patients (63)(64)(65)(66)(67)(68).…”
Section: Discussionmentioning
confidence: 99%
“…Clinical trials with antioxidants for acute illnesses, such as ALI or sepsis, have been disappointing, and no agent has been shown to be effective in critically ill patients (63)(64)(65)(66)(67)(68).…”
Section: Discussionmentioning
confidence: 99%
“…30 min before administration of MAP and a subsequent continuous infusion of NAC (12 mg/kg/h, i.v.) over 8.5 h, with a slight modification of the method reported previously (Molnar et al, 1999;Rank et al, 2000) (Figure 1). …”
Section: Drug Administrationmentioning
confidence: 98%
“…It must be considered, though, that especially IV NAC may be harmful, leading to allergic reactions [247] or decreased cardiac output or survival in patients with septic shock [248,249].…”
Section: Rationalementioning
confidence: 99%